. home.aspx

home.aspx
   

AI and Drug Discovery, Protecting the Value of Data in Collaborations

September 23, 2019 / JEFFREY KANG

AI and Pharma update, Melloddy project—a ground-breaking collaboration between pharmaceutical companies, technology companies, and academic institutions to accelerate drug discovery by sharing pharmaceutical industry data. As we explained, the Melloddy project uses federated learning and blockchain technology to train machine learning (ML) engines using a decentralized architecture that protects each partner’s proprietary data. The Melloddy project is part of a growing trend of using AI/ML in the pharmaceutical industry, which we investigated in Part 1 of our update. In this some of the legal issues surrounding the use of AI/ML in collaborative drug discovery and some solutions for addressing these issues.